UK markets open in 6 hours 22 minutes

Verona Pharma plc (VRNA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
13.36-0.59 (-4.23%)
At close: 04:00PM EDT
13.05 -0.31 (-2.32%)
After hours: 04:03PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-63,420
-54,369
-68,701
-55,569
-65,146
Depreciation & amortisation
783
677
636
629
623
Stock-based compensation
18,980
19,012
14,121
25,425
22,177
Change in working capital
-13,981
-13,898
-10,738
13,444
-2,113
Accounts payable
-2,586
486
-7,146
9,866
-1,398
Other working capital
-58,066
-50,222
-59,891
-33,266
-45,158
Other non-cash items
303
222
188
239
18
Net cash provided by operating activities
-58,050
-50,222
-59,862
-33,254
-45,076
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-29
-12
-82
Purchases of investments
-
-
-
-
0
Sales/maturities of investments
-
-
-
0
9,792
Net cash used for investing activities
-16
0
-29
-12
9,710
Cash flows from financing activities
Debt repayment
-
0
-5,000
0
-
Common stock issued
47
56,909
149,797
733
200,156
Other financing activities
-
-4,697
-15,351
-6,850
-12,856
Net cash used provided by (used for) financing activities
21,061
92,869
140,818
-6,117
192,343
Net change in cash
-36,533
43,945
79,447
-39,606
157,558
Cash at beginning of period
291,415
227,827
148,380
187,986
30,428
Cash at end of period
254,410
271,772
227,827
148,380
187,986
Free cash flow
Operating cash flow
-58,050
-50,222
-59,862
-33,254
-45,076
Capital expenditure
-
-
-29
-12
-82
Free cash flow
-58,066
-50,222
-59,891
-33,266
-45,158